Bell Investment Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $976 | Hold |
107
| – | – | ﹤0.01% | 1593 |
|
2025
Q1 | $851 | Hold |
107
| – | – | ﹤0.01% | 1605 |
|
2024
Q4 | $582 | Buy |
107
+89
| +494% | +$484 | ﹤0.01% | 1725 |
|
2024
Q3 | $130 | Hold |
18
| – | – | ﹤0.01% | 1865 |
|
2024
Q2 | $196 | Hold |
18
| – | – | ﹤0.01% | 1922 |
|
2024
Q1 | $338 | Hold |
18
| – | – | ﹤0.01% | 1880 |
|
2023
Q4 | $391 | Hold |
18
| – | – | ﹤0.01% | 1870 |
|
2023
Q3 | $371 | Sell |
18
-14
| -44% | -$289 | ﹤0.01% | 1874 |
|
2023
Q2 | $1.51K | Hold |
32
| – | – | ﹤0.01% | 1433 |
|
2023
Q1 | $1.34K | Hold |
32
| – | – | ﹤0.01% | 1444 |
|
2022
Q4 | $1.22K | Hold |
32
| – | – | ﹤0.01% | 1499 |
|
2022
Q3 | $1K | Hold |
32
| – | – | ﹤0.01% | 1555 |
|
2022
Q2 | $1K | Buy |
+32
| New | +$1K | ﹤0.01% | 1580 |
|
2021
Q4 | $1K | Buy |
35
+26
| +289% | +$743 | ﹤0.01% | 1587 |
|
2021
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1813 |
|